GAD2 and type 1 diabetes mellitus: Within the patients diagnosed with both T1D and epilepsy (n = 10), six patients (#13, #14 #34, #35, #36, #37) shared GAD65Ab characteristics with patients diagnosed with epilepsy only, and significantly inhibited GAD65 enzyme activity.